(-)-Epigallocatechin-3-gallate decreases thrombin/paclitaxel-induced endothelial tissue factor expression via the inhibition of c-Jun terminal NH2 kinase phosphorylation

Biochemical and Biophysical Research Communications
Huang-Joe WangHaimei Huang

Abstract

Patients with paclitaxel-eluting stents are concerned with stent thrombosis caused by premature discontinuation of dual antiplatelet therapy or clopidogrel resistance. This study investigates the effect of (-)-epigallocatechin-3-gallate (EGCG) on the expression of thrombin/paclitaxel-induced endothelial tissue factor (TF) expressions in human aortic endothelial cells (HAECs). EGCG was nontoxic to HAECs at 6h up to a concentration of 25 micromol/L. At a concentration of 25 micromol/L, EGCG pretreatment potently inhibited both thrombin-stimulated and thrombin/paclitaxel-stimulated endothelial TF protein expression. Thrombin and thrombin/paclitaxel-induced 2.6-fold and 2.9-fold increases in TF activity compared with the control. EGCG pretreatment caused a 29% and 38% decrease in TF activity on thrombin and thrombin/paclitaxel treatment, respectively. Real-time polymerase chain reaction (PCR) showed that thrombin and thrombin/paclitaxel-induced 3.0-fold and 4.6-fold TF mRNA expressions compared with the control. EGCG pretreatment caused an 82% and 72% decrease in TF mRNA expression on thrombin and thrombin/paclitaxel treatment, respectively. The c-Jun terminal NH2 kinase (JNK) inhibitor SP600125 reduced thrombin/paclitaxel-induced ...Continue Reading

References

Aug 5, 2000·Journal of Natural Products·P G Pietta
Sep 26, 2002·Thrombosis Research·Usha R Pendurthi, L Vijaya Mohan Rao
Mar 17, 2004·Free Radical Biology & Medicine·Robert J WilliamsCatherine Rice-Evans
Nov 27, 2004·Journal of Cell Science·Jochen HessMarina Schorpp-Kistner
Nov 8, 2005·European Journal of Pharmacology·Tom J ParryJohn Siekierka
Oct 2, 2007·Journal of the American College of Nutrition·Swen Wolfram
Dec 20, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Hans K Biesalski
Aug 23, 2008·Journal of the American College of Cardiology·Anna Maria GoriDavid Antoniucci
Nov 11, 2008·International Immunopharmacology·Huang-Joe WangHuey-Chun Huang
Mar 13, 2009·Clinical Pharmacology and Therapeutics·G MaluendaR Waksman
Apr 14, 2009·Current Atherosclerosis Reports·Ali J Marian
Aug 29, 2009·Journal of Molecular and Cellular Cardiology·Erik W HolyFelix C Tanner

❮ Previous
Next ❯

Citations

Dec 19, 2012·Biochemical and Biophysical Research Communications·Huang-Joe WangLi-Jen Lin
Jan 22, 2019·Molecular Medicine Reports·Lili PanNing Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.